Cargando…
The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study
BACKGROUND: The real-world effect of intermittently scanned continuous glucose monitoring on glucose control in type 2 diabetes treated with basal insulin is uncertain. This retrospective real-world study aimed to evaluate change in glycated hemoglobin (HbA1c) amongst adults with type 2 diabetes man...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481728/ https://www.ncbi.nlm.nih.gov/pubmed/34275385 http://dx.doi.org/10.1177/14791641211021374 |
_version_ | 1784576742468354048 |
---|---|
author | Elliott, Tom Beca, Sorin Beharry, Rajendra Tsoukas, Michael A Zarruk, Alexandro Abitbol, Alexander |
author_facet | Elliott, Tom Beca, Sorin Beharry, Rajendra Tsoukas, Michael A Zarruk, Alexandro Abitbol, Alexander |
author_sort | Elliott, Tom |
collection | PubMed |
description | BACKGROUND: The real-world effect of intermittently scanned continuous glucose monitoring on glucose control in type 2 diabetes treated with basal insulin is uncertain. This retrospective real-world study aimed to evaluate change in glycated hemoglobin (HbA1c) amongst adults with type 2 diabetes managed with basal insulin starting flash glucose monitoring. METHODS: Medical records were reviewed for adults with type 2 diabetes treated with basal insulin for ⩾1 year and using FreeStyle Libre(TM) Flash Glucose Monitoring for ⩾3 months. Prior to device use an HbA1c 8.0%–12.0% was recorded and a further HbA1c result was recorded 3–6 months (90–194 days) after starting device use. RESULTS: Medical records (n = 91) analyzed from six Canadian diabetes centers showed HbA1c significantly decreased by 0.8% ± 1.1 (mean ± SD, [p < 0.0001]) from mean baseline HbA1c 8.9% ± 0.9 to 8.1% ± 1.0 at 3–6 months after initiating flash glucose monitoring. HbA1c improvement was not independently associated with age, BMI, insulin use duration, or sex. CONCLUSION: This Canadian real-world retrospective study showed significantly reduced HbA1c following initiation of flash glucose monitoring technology to further support management of type 2 diabetes treated with basal insulin. |
format | Online Article Text |
id | pubmed-8481728 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-84817282021-10-01 The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study Elliott, Tom Beca, Sorin Beharry, Rajendra Tsoukas, Michael A Zarruk, Alexandro Abitbol, Alexander Diab Vasc Dis Res Brief Report BACKGROUND: The real-world effect of intermittently scanned continuous glucose monitoring on glucose control in type 2 diabetes treated with basal insulin is uncertain. This retrospective real-world study aimed to evaluate change in glycated hemoglobin (HbA1c) amongst adults with type 2 diabetes managed with basal insulin starting flash glucose monitoring. METHODS: Medical records were reviewed for adults with type 2 diabetes treated with basal insulin for ⩾1 year and using FreeStyle Libre(TM) Flash Glucose Monitoring for ⩾3 months. Prior to device use an HbA1c 8.0%–12.0% was recorded and a further HbA1c result was recorded 3–6 months (90–194 days) after starting device use. RESULTS: Medical records (n = 91) analyzed from six Canadian diabetes centers showed HbA1c significantly decreased by 0.8% ± 1.1 (mean ± SD, [p < 0.0001]) from mean baseline HbA1c 8.9% ± 0.9 to 8.1% ± 1.0 at 3–6 months after initiating flash glucose monitoring. HbA1c improvement was not independently associated with age, BMI, insulin use duration, or sex. CONCLUSION: This Canadian real-world retrospective study showed significantly reduced HbA1c following initiation of flash glucose monitoring technology to further support management of type 2 diabetes treated with basal insulin. SAGE Publications 2021-07-17 /pmc/articles/PMC8481728/ /pubmed/34275385 http://dx.doi.org/10.1177/14791641211021374 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Brief Report Elliott, Tom Beca, Sorin Beharry, Rajendra Tsoukas, Michael A Zarruk, Alexandro Abitbol, Alexander The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study |
title | The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study |
title_full | The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study |
title_fullStr | The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study |
title_full_unstemmed | The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study |
title_short | The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study |
title_sort | impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in canada: a retrospective real-world chart review study |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481728/ https://www.ncbi.nlm.nih.gov/pubmed/34275385 http://dx.doi.org/10.1177/14791641211021374 |
work_keys_str_mv | AT elliotttom theimpactofflashglucosemonitoringonglycatedhemoglobinintype2diabetesmanagedwithbasalinsulinincanadaaretrospectiverealworldchartreviewstudy AT becasorin theimpactofflashglucosemonitoringonglycatedhemoglobinintype2diabetesmanagedwithbasalinsulinincanadaaretrospectiverealworldchartreviewstudy AT beharryrajendra theimpactofflashglucosemonitoringonglycatedhemoglobinintype2diabetesmanagedwithbasalinsulinincanadaaretrospectiverealworldchartreviewstudy AT tsoukasmichaela theimpactofflashglucosemonitoringonglycatedhemoglobinintype2diabetesmanagedwithbasalinsulinincanadaaretrospectiverealworldchartreviewstudy AT zarrukalexandro theimpactofflashglucosemonitoringonglycatedhemoglobinintype2diabetesmanagedwithbasalinsulinincanadaaretrospectiverealworldchartreviewstudy AT abitbolalexander theimpactofflashglucosemonitoringonglycatedhemoglobinintype2diabetesmanagedwithbasalinsulinincanadaaretrospectiverealworldchartreviewstudy AT elliotttom impactofflashglucosemonitoringonglycatedhemoglobinintype2diabetesmanagedwithbasalinsulinincanadaaretrospectiverealworldchartreviewstudy AT becasorin impactofflashglucosemonitoringonglycatedhemoglobinintype2diabetesmanagedwithbasalinsulinincanadaaretrospectiverealworldchartreviewstudy AT beharryrajendra impactofflashglucosemonitoringonglycatedhemoglobinintype2diabetesmanagedwithbasalinsulinincanadaaretrospectiverealworldchartreviewstudy AT tsoukasmichaela impactofflashglucosemonitoringonglycatedhemoglobinintype2diabetesmanagedwithbasalinsulinincanadaaretrospectiverealworldchartreviewstudy AT zarrukalexandro impactofflashglucosemonitoringonglycatedhemoglobinintype2diabetesmanagedwithbasalinsulinincanadaaretrospectiverealworldchartreviewstudy AT abitbolalexander impactofflashglucosemonitoringonglycatedhemoglobinintype2diabetesmanagedwithbasalinsulinincanadaaretrospectiverealworldchartreviewstudy |